New book by Larry Connors Click here Improve your trading - See how
Denton, who is currently the company's Senior Vice President, Controller and Chief Accounting Officer, will succeed David Rickard who announced in February this year his intention to retire as CFO. Denton joined the company in 1999.
The selection of Denton as Chief Financial Officer ends an eight month search that included both internal and external candidates, CVS said in a statement.
Laird Daniels, most recently the company's Vice President of Finance and Retail Controller for CVS/pharmacy, will be replacing Denton as Controller and Chief Accounting Officer of CVS Caremark. Daniels joined the company in 1997.
Separately, CVS Caremark said that its Board of Directors has approved a new stock buyback program to repurchase up to $2 billion of its common stock. The authorization, which is effective immediately, expires at the end of 2011.
Earlier Thursday, CVS Caremark reported a 39% rise in its third quarter profit, reflecting double-digit segmental revenue growth.
Net income available to the common shareholders for the third quarter rose to $1.02 billion or $0.71 per share from $732.5 million or $0.50 per share in the prior-year quarter.
Income from continuing operations for the quarter increased to $1.02 billion or $0.71 per share from $818.8 million or $0.56 per share a year ago.
Adjusted earnings from continuing operations for the quarter increased to $1.01 billion or $0.76 per share from $877.5 million or $0.60 per share in the year-ago quarter.
Analysts polled by Thomson Reuters expected the company to report earnings of $0.64 per share. Analysts' estimates typically exclude special items.
Net revenues for the third quarter rose 18.1% to $24.64 billion from $20.86 billion in the year-ago quarter, and beat analysts' consensus revenue estimate of $24.61 billion.
Looking ahead, the company said it now expects full year 2009 adjusted earnings to be $2.61 to $2.64 per share, compared to its prior guidance of $2.59 to $2.64 per share. Analysts currently expect the company to report earnings of $2.62 per share for the year.
During a conference call with analysts, CVS Chief Executive Officer and Chairman Tom Ryan said the company's pharmacy benefits management business lost $3.7 billion in contracts in the third quarter. The $3.7 billion in lost contracts brings this year's total to $4.8 billion, Ryan said.
Ryan also said Howard McClure, President of Caremark Pharmacy Services, will be retiring effective November 27. Ryan said he will take over McClure's role on an interim basis while the company conducts a search.
For comments and feedback: contact editorial@rttnews.com Copyright(c) 2009 RTTNews.com, Inc. All Rights Reserved
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
